Pharmaceuticals

Pharmaceuticals, printers and paintballs: when variability in excipient quality is and isn’t acceptable

Excipient Quality blog post thumbnail.

Regardless of whether it’s prescription or over-the-counter, the ingredients on a drug product label typically include one, maybe two, active pharmaceutical ingredients (APIs). The rest of the list is comprised of “inactive” ingredients (excipients) which in reality are far from inactive. Variability may be acceptable for products such as printer ink and paintballs, but not pharmaceuticals, making quality standards for excipients critical to ensuring consistent drug quality.

Share

Exploring Continuous Manufacturing Technology and Applications in the Pharmaceutical Industry

Pharmaceutical continuous manufacturing

As more drug makers adopt pharmaceutical continuous manufacturing, new technological developments and operational demands are resulting from new partnerships among academic centers and industry leaders, particularly in the past two years.  To this goal, USP recently formalized collaborations with Center for Structured Organic Particulate Systems (C-SOPS), a leader in research on PCM. Learn more about the opportunities in this field.

Share

Exploring the Promise and Challenges of Nanomedicines

Nanomedicines Opportunities and Challenges

Nanomedicine—the use of nanoscale materials and technologies to treat diseases at the molecular level—has shown promising results in patient care, particularly in oncology. While this potential has led to increased research, there are challenges surrounding nomenclature, characterization and environmental impact. Learn how you can collaborate with USP to help determine a path foward.

Share

Pages